- Home
- Publications
- Publication Search
- Publication Details
Title
The safety of oral antifungals for the treatment of onychomycosis
Authors
Keywords
-
Journal
Expert Opinion On Drug Safety
Volume -, Issue -, Pages -
Publisher
Informa UK Limited
Online
2023-11-06
DOI
10.1080/14740338.2023.2280137
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combatting antifungal resistance: Paradigm shift in the diagnosis and management of onychomycosis and dermatomycosis
- (2023) Aditya K. Gupta et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Updated Perspectives on the Diagnosis and Management of Onychomycosis
- (2022) Julianne M Falotico et al. Clinical Cosmetic and Investigational Dermatology
- Antifungal agents and the kidney: pharmacokinetics, clinical nephrotoxicity, and interactions
- (2021) Athanasios Tragiannidis et al. Expert Opinion On Drug Safety
- Antifungal Resistance in Dermatophytes: Genetic Considerations, Clinical Presentations and Alternative Therapies
- (2021) Rosalie Sacheli et al. Journal of Fungi
- Evaluation of Association Between Oral and Topical Terbinafine Use in Pregnancy and Risk of Major Malformations and Spontaneous Abortion
- (2020) Niklas Worm Andersson et al. JAMA Dermatology
- Onychomycosis: a review
- (2020) Aditya K. Gupta et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Oral fluconazole use in the first trimester and risk of congenital malformations: population based cohort study
- (2020) Yanmin Zhu et al. BMJ-British Medical Journal
- Successful treatment of resistant onychomycosis with voriconazole in a liver transplant patient
- (2020) Ahmad Nofal et al. Dermatologic Therapy
- Safety of current therapies for onychomycosis
- (2020) Jose W. Ricardo et al. Expert Opinion On Drug Safety
- Associations between low- and high-dose oral fluconazole and pregnancy outcomes: 3 nested case–control studies
- (2019) Anick Bérard et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- When medicine transforms art
- (2019) Sara Belga et al. Transplant Infectious Disease
- Utility of Laboratory Test Result Monitoring in Patients Taking Oral Terbinafine or Griseofulvin for Dermatophyte Infections
- (2018) Deirdre A. Stolmeier et al. JAMA Dermatology
- Cytochrome P450 and P-Glycoprotein-Mediated Interactions Involving African Herbs Indicated for Common Noncommunicable Diseases
- (2017) Gregory Ondieki et al. Evidence-based Complementary and Alternative Medicine
- Acute liver failure induced by idiosyncratic reaction to drugs: Challenges in diagnosis and therapy
- (2017) Shannan R. Tujios et al. LIVER INTERNATIONAL
- Chemical inhibitors of Candida albicans hyphal morphogenesis target endocytosis
- (2017) Hagit Bar-Yosef et al. Scientific Reports
- Hepatotoxicity of Antimycotics Used for Invasive Fungal Infections: In Vitro Results
- (2017) Sandra Doß et al. Biomed Research International
- The Transduction Cascade in Retinal ON-Bipolar Cells: Signal Processing and Disease
- (2017) Kirill A. Martemyanov et al. Annual Review of Vision Science
- Oral Azole Antifungal Medications and Risk of Acute Liver Injury, Overall and by Chronic Liver Disease Status
- (2016) Vincent Lo Re et al. AMERICAN JOURNAL OF MEDICINE
- Inhibitory Potential of Antifungal Drugs on ATP-Binding Cassette Transporters P-Glycoprotein, MRP1 to MRP5, BCRP, and BSEP
- (2016) Vincent J. C. Lempers et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans
- (2016) Minjun Chen et al. DRUG DISCOVERY TODAY
- Onychomycosis
- (2016) Tracey C. Vlahovic Clinics in Podiatric Medicine and Surgery
- Voriconazole-associated visual disturbances and hallucinations
- (2015) Gulsum Iclal Bayhan et al. Cutaneous and Ocular Toxicology
- Voriconazole, an Antifungal Triazol That Causes Visual Side Effects, Is an Inhibitor of TRPM1 and TRPM3 Channels
- (2015) W.-H. Xiong et al. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
- Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease
- (2015) Oliver A. Cornely et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Identification of fungi species in the onychomycosis of institutionalized elderly
- (2013) Cidia Vasconcellos et al. ANAIS BRASILEIROS DE DERMATOLOGIA
- Risk of oral antifungal agent-induced liver injury in Taiwanese
- (2013) Wei-Yu Kao et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Determination of Posaconazole Levels in Toenails of Adults with Onychomycosis following Oral Treatment with Four Regimens of Posaconazole for 12 or 24 Weeks
- (2011) Gopal Krishna et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Peripheral neuropathy in patients on long-term triazole antifungal therapy
- (2011) C. G. Baxter et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- TRPM1: The endpoint of the mGluR6 signal transduction cascade in retinal ON-bipolar cells
- (2010) Catherine W. Morgans et al. BIOESSAYS
- In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis
- (2009) J. G. Bueno et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now